Fig. 2From: The integration of multidisciplinary approaches revealed PTGES3 as a novel drug target for breast cancer treatmentValidation of the risk model basing on six-gene in GEO and METABRIC cohort. a, e DCA analysis. b, f The distributions of overall survival status, overall survival and risk score; Hierarchical clustering of six core genes between low- and high-risk groups. Red, up-regulated; Blue, down-regulated. c, g Kaplan–Meier survival curve based on the six-gene signature. d, h ROC curve of the 6-gene signature for 1-year, 3-year and 5-year survivalBack to article page